Department of Immunotechnology
11 – 20 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Variations in critical quality attributes (CQAs) on therapeutic monoclonal antibodies (mAbs) due to cultivation conditions, storage conditions and external stress-factors
(
- Master (Two yrs)
-
Mark
An In Vitro Assay : To Evaluate the Functional Roles of Peroxisomes in Normal Hematopoiesis
(
- Master (Two yrs)
- 2023
-
Mark
Dendritic cell stress responses after exposure to a novel rubber skin sensitizer
(
- Master (Two yrs)
-
Mark
Development of in vitro models that test and predict immune-mediated adverse toxicities
(
- Master (Two yrs)
-
Mark
Evaluating targeted combination therapies in EGFR wild-type non-small-cell lung cancer using mass spectrometry-based proteomics
(
- Master (Two yrs)
-
Mark
Investigations of immune population subsets in bladder cancer
(
- Master (Two yrs)
-
Mark
The Effects of Chemotherapy on B Cells and T Cells in Blood and Tumor Tissue in Patients with Pancreatic Cancer – from Diagnosis to Terminal Disease
(
- Master (Two yrs)
-
Mark
Towards Development of Antibodies Targeting Myeloid and Regulatory T Cells in Bladder Tumours
(
- Master (Two yrs)
-
Mark
Mass spectrometry-based proteomic characterization of peripheral immune cells
(
- Master (Two yrs)
-
Mark
Immune cell landscapes in endometriosis and endometriosis-associated ovarian cancer
(
- Master (Two yrs)